Patenton — panteon of patents

(19)

RU

(11)

2 577 311

(13)

C2

(51)

IPC

C07K5/06(2006-01-01)

C07K5/08(2006-01-01)

C07K5/10(2006-01-01)

A61K38/05(2006-01-01)

A61K38/06(2006-01-01)

A61K38/07(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2012120905/04, 2010-10-22

(24)

Start date

2010-10-22

(22)

Actual filing date

2010-10-22

(45)

Published

2016-03-20

(72)

Inventor

Lou Kerolajn Minli RejchelMonti Simona MarijaRuvo MenottiTornatore LauraTralo-Stjuart Keterin DzhejnFrandzozo GidoJaksa-Khamets Albert Andzhej

(73)

Holder

Imperial Innovations Limited

METHOD FOR TREATING OR PREVENTING CANCER DISEASE IN INDIVIDUAL, WHICH IS CHARACTERISED BY HIGH-LEVEL EXPRESSION OR ACTIVITY OF Gadd45β (AS COMPARED TO COMMON CIVILISED CELLS) IF CANCER CELL VIABILITY AND/OR GROWTH ARE/IS STATED DEPENDENT ON NF-kB, AND TRIPEPTIDE Russian patent published in 2016 - IPC C07K5/06 C07K5/08 C07K5/10 A61K38/05 A61K38/06 A61K38/07 A61P35/00 

Abstract RU 2577311 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to using the compounds based on tetrapeptide and tripeptide groups and related peptoid groups in treating or preventing a cancer disease in an individual, which is characterised by a high-level expression or activity of Gadd45β as compared to common civilised cells if cancer cell viability and/or growth are/is stated dependent on NF-κB.

EFFECT: higher effectiveness of the method.

14 cl, 54 dwg, 9 tbl, 15 ex

Similar patents RU2577311C2

Title Year Author Number
HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-T CELLS 2020
  • Wu, Lijun
  • Golubovskaya, Vita
 RU2762942C1
HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-NK-CELLS 2020
  • Wu, Lijun
  • Golubovskaya, Vita
 RU2795443C2
COMBINATION CANCER THERAPIES TARGETTING CD38 AND TGF-BETA 2019
  • Adrian, Francisco
  • Gregory, Richard C.
  • Shapiro, Gary
  • Van De Velde, Helgi
 RU2808632C2
ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER DISEASES 2019
  • Launay, Pierre
  • Souchet, Herve
  • Belanger, Coralie
 RU2799547C2
ANTI-CD38 ANTIBODIES AND FORMULATIONS 2020
  • Cameron, Beatrice
  • Chiron Blondel, Marielle
  • Dumas, Jacques
  • Fournier, Alain
  • Kingsbury, Jonathan
  • Lemoine, Cendrine
  • Murray, Brian
  • Ostberg, Nathan
  • Patke, Sanket
  • Virone-Oddos, Angela
  • Zhang, Zichuan
 RU2826957C2
METHOD AND COMPOSITION FOR TREATING CANCER, DESTROYING METASTATIC CANCER CELLS AND PREVENTING METASTASES OF CANCER, USING ANTIBODIES TO END PRODUCTS OF INCREASED GLYCATION (AGE) 2017
  • Gruber, Lewis, S.
 RU2728964C2
AGENTS FOR THE TREATMENT OF CLAUDINE-EXPRESSING CANCER DISEASES 2013
  • Sakhin, Ugur
  • Tyurechi, Ezlem
  • Shtadler Kristiane
  • Kholland, Yuliya
  • Ber-Makhmud, Khayat
  • Bajssert, Tim
  • Plyum, Laura
  • Le Gol, Fabris
  • Jendretski, Arne
  • Fidler, Markus
 RU2798990C2
HUMANIZED ANTIBODIES AGAINST CD269 (BCMA) 2015
  • Oden, Felix
  • Marino, Stephen
  • Daumke, Oliver
 RU2749041C2
ANTI-FcRH5 ANTIBODIES 2014
  • Ebens, Allen, Dzh., Ml.
  • Khejzen, Meredit, K.
  • Khongo, Dzho-Enn
  • Dzhonston, Dzhennifer, V.
  • Dzhunttila, Teemu, T.
  • Li, Tszi
  • Polson, Endryu, G.
 RU2687132C2
AMHRII BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCER 2018
  • Barret Jean-Marc
  • Prost Jean-Francois
  • Lahmar Mehdi
  • Degove Stephane
  • Dubreuil Olivier
  • Nicolas Andre
  • Meseure Didier
 RU2816523C2

RU 2 577 311 C2

Authors

Lou Kerolajn Minli Rejchel

Monti Simona Marija

Ruvo Menotti

Tornatore Laura

Tralo-Stjuart Keterin Dzhejn

Frandzozo Gido

Jaksa-Khamets Albert Andzhej

Dates

2016-03-20—Published

2010-10-22—Filed

download Download PDF read Similar patents